Scoping Review of Antimalarial Drug Candidates in Phase I and II Drug Development
February 15, 2022
The emergence and spread of parasite resistance to currently available antimalarials has highlighted the importance of developing novel antimalarials. This…
Global diversity and balancing selection of 23 leading Plasmodium falciparum candidate vaccine antigens
February 2, 2022
Investigation of the diversity of malaria parasite antigens can help prioritize and validate them as vaccine candidates and identify the…
Tafenoquine for children: a step towards implementation
February 1, 2022
After several decades of development, tafenoquine, an 8-aminoquinoline compound, was registered by the US Food and Drug Administration on July…